J immunol:IL-4, IL-21, 与IFN-γ共同调节激活B细胞T-bet基因表达

2016-07-21 佚名 生物谷

尽管T-bet最初被发现作用了CD4 T细胞的分化,但它也同样参与了多种免疫细胞的转录调节活动。在慢性病毒感染中,B细胞内部的T-bet的能够促进其产生IgG2a,从而抑制病毒的感染。另外,T-bet也参与了与年龄相关的B细胞的产生,这部分B细胞与常规B细胞不同,但对病毒的清除以及自体体液免疫反应同样重要。最后,大部分T-bet阳性的B细胞都表达CD11c,这一表型特征标志着机体存在病毒、细菌或其

尽管T-bet最初被发现作用了CD4 T细胞的分化,但它也同样参与了多种免疫细胞的转录调节活动。在慢性病毒感染中,B细胞内部的T-bet的能够促进其产生IgG2a,从而抑制病毒的感染。另外,T-bet也参与了与年龄相关的B细胞的产生,这部分B细胞与常规B细胞不同,但对病毒的清除以及自体体液免疫反应同样重要。最后,大部分T-bet阳性的B细胞都表达CD11c,这一表型特征标志着机体存在病毒、细菌或其它病原体的感染。

尽管越来越多的证据表明T-bet阳性B细胞的生理作用,但这一亚群细胞的产生机制,以及其生理功能的调节过程都不太清楚。此前研究表明后天或先天的免疫受体,包括BCR以及TLR以及来自Tfh细胞的信号等都参与了T-bet阳性B细胞的分化与效应。具体地,IL-12、IL-18、IFN-g等都能够引起活化B细胞中T-bet转录因子的表达。不过,这些因子调节T-bet表达的胞内信号通路仍然没有完全揭示。

针对这一问题,来自美国宾夕法尼亚大学医学院的Michael P. Cancro课题组进行了深入研究,相关结果发表在最近一期的《Journal of Immunology》杂志上。

首先,作者通过体外刺激B细胞表面的TLR9受体,并给予IL-21的刺激,结果显示,IL-21能够进一步上调受到TL-9刺激后的B细胞中的T-bet基因的表达。进一步,作者发现IFN-g也具有上述效果,但IL-4则能够抑制IL-21引起的T-bet的表达。为了研究IL-21与IL-4是否直接调节了B细胞中T-bet的表达,作者将野生型B细胞与IL21r-/-或Stat-/-B细胞进行共同孵育。其中IL21R是IL-21的受体,而STAT6则是IL-4信号通路中的关键元件。作者希望了解这种共同孵育的操作能否产生一些细胞间的传递效应。结果显示,虽然IL-21能够促进野生型B细胞中T-bet的表达,而共同培养物中的突变体B细胞则始终呈T-bet阴性。这一结果表明IL-21信号直接调节了T-bet的活化。同样的,作者也证明了IL-4的抑制作用也是直接作用于IL-21信号本身。

进一步,作者通过体内试验验证了上述三种细胞因子能够调节胞内T-bet阳性、CD11c阳性的B细胞的形成,而IL-21促进CD11c的表达并不依赖于T-bet的活化。在流感病毒感染过程中,由于B细胞中的天然免疫受体被病毒抗原激活,即使缺少IFN-g,机体也能够产生T-bet、CD11c双阳性的B细胞,尽管此时常规B细胞的数量有明显的缺陷。

综上,作者证明了IL-4与IL-21协同作用调节了T-bet、CD11c双阳性B细胞的产生,这一过程并不依赖于IFN-g。

原始出处

Martin S. Naradikian, Arpita Myles, Daniel P. Beiting, Kenneth J. Roberts, Lucas Dawson, Ramin Sedaghat Herati, Bertram Bengsch, Susanne L. Linderman, Erietta Stelekati, Rosanne Spolski#, E. John Wherry, Christopher Hunter, Scott E. Hensley, Warren J. Leonard and Michael P. Cancro.Cutting Edge: IL-4, IL-21, and IFN-γ Interact To Govern T-bet and CD11c Expression in TLR-Activated B Cells.J immunol.2016

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1778458, encodeId=e5821e78458dd, content=<a href='/topic/show?id=51f09653ba' target=_blank style='color:#2F92EE;'>#IL-21#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9653, encryptionId=51f09653ba, topicName=IL-21)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=753a39257265, createdName=baoya, createdTime=Thu Mar 02 05:43:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759720, encodeId=652e1e597203b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Sep 04 18:43:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795554, encodeId=d0881e9555497, content=<a href='/topic/show?id=a7581e01458' target=_blank style='color:#2F92EE;'>#T-bet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17014, encryptionId=a7581e01458, topicName=T-bet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Nov 08 19:43:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273172, encodeId=98bb12e3172bf, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3837, encryptionId=310d383ef5, topicName=B细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348019, encodeId=60911348019e0, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519018, encodeId=eaaf151901844, content=<a href='/topic/show?id=ba989452f5' target=_blank style='color:#2F92EE;'>#IFN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9452, encryptionId=ba989452f5, topicName=IFN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32b711235060, createdName=bugit, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626027, encodeId=26e1162602e0c, content=<a href='/topic/show?id=87369652f3' target=_blank style='color:#2F92EE;'>#IL-2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9652, encryptionId=87369652f3, topicName=IL-2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea8220955712, createdName=tomyang93, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=)]
    2017-03-02 baoya
  2. [GetPortalCommentsPageByObjectIdResponse(id=1778458, encodeId=e5821e78458dd, content=<a href='/topic/show?id=51f09653ba' target=_blank style='color:#2F92EE;'>#IL-21#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9653, encryptionId=51f09653ba, topicName=IL-21)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=753a39257265, createdName=baoya, createdTime=Thu Mar 02 05:43:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759720, encodeId=652e1e597203b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Sep 04 18:43:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795554, encodeId=d0881e9555497, content=<a href='/topic/show?id=a7581e01458' target=_blank style='color:#2F92EE;'>#T-bet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17014, encryptionId=a7581e01458, topicName=T-bet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Nov 08 19:43:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273172, encodeId=98bb12e3172bf, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3837, encryptionId=310d383ef5, topicName=B细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348019, encodeId=60911348019e0, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519018, encodeId=eaaf151901844, content=<a href='/topic/show?id=ba989452f5' target=_blank style='color:#2F92EE;'>#IFN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9452, encryptionId=ba989452f5, topicName=IFN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32b711235060, createdName=bugit, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626027, encodeId=26e1162602e0c, content=<a href='/topic/show?id=87369652f3' target=_blank style='color:#2F92EE;'>#IL-2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9652, encryptionId=87369652f3, topicName=IL-2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea8220955712, createdName=tomyang93, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1778458, encodeId=e5821e78458dd, content=<a href='/topic/show?id=51f09653ba' target=_blank style='color:#2F92EE;'>#IL-21#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9653, encryptionId=51f09653ba, topicName=IL-21)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=753a39257265, createdName=baoya, createdTime=Thu Mar 02 05:43:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759720, encodeId=652e1e597203b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Sep 04 18:43:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795554, encodeId=d0881e9555497, content=<a href='/topic/show?id=a7581e01458' target=_blank style='color:#2F92EE;'>#T-bet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17014, encryptionId=a7581e01458, topicName=T-bet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Nov 08 19:43:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273172, encodeId=98bb12e3172bf, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3837, encryptionId=310d383ef5, topicName=B细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348019, encodeId=60911348019e0, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519018, encodeId=eaaf151901844, content=<a href='/topic/show?id=ba989452f5' target=_blank style='color:#2F92EE;'>#IFN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9452, encryptionId=ba989452f5, topicName=IFN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32b711235060, createdName=bugit, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626027, encodeId=26e1162602e0c, content=<a href='/topic/show?id=87369652f3' target=_blank style='color:#2F92EE;'>#IL-2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9652, encryptionId=87369652f3, topicName=IL-2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea8220955712, createdName=tomyang93, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=)]
    2016-11-08 yuanming7
  4. [GetPortalCommentsPageByObjectIdResponse(id=1778458, encodeId=e5821e78458dd, content=<a href='/topic/show?id=51f09653ba' target=_blank style='color:#2F92EE;'>#IL-21#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9653, encryptionId=51f09653ba, topicName=IL-21)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=753a39257265, createdName=baoya, createdTime=Thu Mar 02 05:43:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759720, encodeId=652e1e597203b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Sep 04 18:43:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795554, encodeId=d0881e9555497, content=<a href='/topic/show?id=a7581e01458' target=_blank style='color:#2F92EE;'>#T-bet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17014, encryptionId=a7581e01458, topicName=T-bet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Nov 08 19:43:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273172, encodeId=98bb12e3172bf, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3837, encryptionId=310d383ef5, topicName=B细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348019, encodeId=60911348019e0, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519018, encodeId=eaaf151901844, content=<a href='/topic/show?id=ba989452f5' target=_blank style='color:#2F92EE;'>#IFN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9452, encryptionId=ba989452f5, topicName=IFN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32b711235060, createdName=bugit, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626027, encodeId=26e1162602e0c, content=<a href='/topic/show?id=87369652f3' target=_blank style='color:#2F92EE;'>#IL-2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9652, encryptionId=87369652f3, topicName=IL-2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea8220955712, createdName=tomyang93, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1778458, encodeId=e5821e78458dd, content=<a href='/topic/show?id=51f09653ba' target=_blank style='color:#2F92EE;'>#IL-21#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9653, encryptionId=51f09653ba, topicName=IL-21)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=753a39257265, createdName=baoya, createdTime=Thu Mar 02 05:43:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759720, encodeId=652e1e597203b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Sep 04 18:43:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795554, encodeId=d0881e9555497, content=<a href='/topic/show?id=a7581e01458' target=_blank style='color:#2F92EE;'>#T-bet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17014, encryptionId=a7581e01458, topicName=T-bet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Nov 08 19:43:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273172, encodeId=98bb12e3172bf, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3837, encryptionId=310d383ef5, topicName=B细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348019, encodeId=60911348019e0, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519018, encodeId=eaaf151901844, content=<a href='/topic/show?id=ba989452f5' target=_blank style='color:#2F92EE;'>#IFN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9452, encryptionId=ba989452f5, topicName=IFN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32b711235060, createdName=bugit, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626027, encodeId=26e1162602e0c, content=<a href='/topic/show?id=87369652f3' target=_blank style='color:#2F92EE;'>#IL-2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9652, encryptionId=87369652f3, topicName=IL-2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea8220955712, createdName=tomyang93, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1778458, encodeId=e5821e78458dd, content=<a href='/topic/show?id=51f09653ba' target=_blank style='color:#2F92EE;'>#IL-21#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9653, encryptionId=51f09653ba, topicName=IL-21)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=753a39257265, createdName=baoya, createdTime=Thu Mar 02 05:43:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759720, encodeId=652e1e597203b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Sep 04 18:43:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795554, encodeId=d0881e9555497, content=<a href='/topic/show?id=a7581e01458' target=_blank style='color:#2F92EE;'>#T-bet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17014, encryptionId=a7581e01458, topicName=T-bet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Nov 08 19:43:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273172, encodeId=98bb12e3172bf, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3837, encryptionId=310d383ef5, topicName=B细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348019, encodeId=60911348019e0, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519018, encodeId=eaaf151901844, content=<a href='/topic/show?id=ba989452f5' target=_blank style='color:#2F92EE;'>#IFN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9452, encryptionId=ba989452f5, topicName=IFN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32b711235060, createdName=bugit, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626027, encodeId=26e1162602e0c, content=<a href='/topic/show?id=87369652f3' target=_blank style='color:#2F92EE;'>#IL-2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9652, encryptionId=87369652f3, topicName=IL-2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea8220955712, createdName=tomyang93, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=)]
    2016-07-23 bugit
  7. [GetPortalCommentsPageByObjectIdResponse(id=1778458, encodeId=e5821e78458dd, content=<a href='/topic/show?id=51f09653ba' target=_blank style='color:#2F92EE;'>#IL-21#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9653, encryptionId=51f09653ba, topicName=IL-21)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=753a39257265, createdName=baoya, createdTime=Thu Mar 02 05:43:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759720, encodeId=652e1e597203b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Sep 04 18:43:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795554, encodeId=d0881e9555497, content=<a href='/topic/show?id=a7581e01458' target=_blank style='color:#2F92EE;'>#T-bet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17014, encryptionId=a7581e01458, topicName=T-bet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Nov 08 19:43:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273172, encodeId=98bb12e3172bf, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3837, encryptionId=310d383ef5, topicName=B细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348019, encodeId=60911348019e0, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519018, encodeId=eaaf151901844, content=<a href='/topic/show?id=ba989452f5' target=_blank style='color:#2F92EE;'>#IFN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9452, encryptionId=ba989452f5, topicName=IFN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32b711235060, createdName=bugit, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626027, encodeId=26e1162602e0c, content=<a href='/topic/show?id=87369652f3' target=_blank style='color:#2F92EE;'>#IL-2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9652, encryptionId=87369652f3, topicName=IL-2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea8220955712, createdName=tomyang93, createdTime=Sat Jul 23 07:43:00 CST 2016, time=2016-07-23, status=1, ipAttribution=)]
    2016-07-23 tomyang93

相关威廉亚洲官网

J Immunol:T胸腺中富集自身反应性B细胞

胸腺是T细胞分化的发生地,也是重要的淋巴器官。始祖T细胞从骨髓出来,经过皮质延髓束进入胸腺,并在其皮质区域进行TCR的重排。之后,表达TCR的这部分T细胞在胸腺中经历了两次重要的选择。首先,它们通过阳性选择检验了其表面的TCR与MHC的结合能力。其中,负责检验的是表面同时表达MHC-I与MHC-II的胸腺表皮细胞。之后,这部分通过了阳性选择的细胞再次经历阴性选择,这一步是为了检验T细胞与自身抗

Science:重大突破!利用CAAR-T细胞疗法靶向治疗自身免疫疾病

在一项新的研究中,来自美国、意大利和瑞士的研究人员发现一种方法将导致自身免疫疾病的一部分制造抗体的B细胞清除,同时不会伤害免疫系统其余部分。他们研究的一种自身免疫疾病被称作寻常性天疱疮(pemphigus vulgaris, PV),在这种疾病中,病人自己的免疫细胞攻击一种在正常条件下将皮肤细胞粘附在一起的被称作桥粒芯蛋白-3(desmoglein-3, Dsg3)的蛋白。相关研究结果于2

Nature:CD4细胞帮助病毒中和抗体进入神经组织

血液中循环流动的抗体能够进入大部分组织对病原体进行清除。而“免疫豁免“的组织与器官,比如大脑与外周神经系统,则会通过血-脑屏障以及血-神经屏障阻止抗体的进入。然而,在某些情况下抗体能够通过某种方式进入这些组织器官内部发挥免疫效应。为了研究这一现象背后的机制,来自耶鲁大学医学院的Akiko Iwasaki课题组利用生殖期孢疹病毒(HSV)感染模型进行了试验,相关结果发表在最近一期的《nature》杂

Nat Immunol:生发中心B细胞向记忆B细胞分化机制

体液免疫依赖于记忆B细胞以及长存活期的效应B细胞(浆细胞)的发育,尽管一些记忆B细胞在生发中心形成以前,经过T-B细胞的初次互作就能够产生,但大部分记忆B细胞依赖于淋巴结的生发中心。 生发中心细胞的动态变化能够通过活体成像技术观测,目前已知生发中心是淋巴结亮区(light zone)与暗区(dark zone)之间的地带,期间充斥了迁移的B细胞。B细胞的增殖以及体细胞超突变发生在 DZ,之后这部

J Immunol:胸腺中存在大量自体反应性B细胞

胸腺是T细胞成熟的初级淋巴器官,前T细胞进入胸腺后能够迁移到皮质区域从而进行TCR的重排。之后,T细胞会发生两个主要的选择事件。首先,TCR会选择性地与MHC分子进行结合,发生阳性选择过程,介导阳性选择过程的主要是皮质区胸腺上皮细胞(TEC)。经过阳性选择留下的胸腺细胞会通过与自身抗原结合进行阴性选择,其中自体抗原是由树突状细胞以及TEC表面的MHC-I与MHC-II呈递的。组织特异性的抗原主要由

J Immunology:BTK介导Tfh分化促进自身免疫反应的发生

在自体免疫病(比如系统性红斑狼疮)的发病过程中,B细胞的稳态失衡是重要的病理学标志。患者的血清中会出现大量针对自体细胞核抗原物质的抗体,这些抗体会沉积在关节,眼睛,皮肤,肺脏以及肾脏中,从而引发炎症反应。此前的研究发现B细胞内部的信号发生紊乱足以导致自体免疫疾病的发生,但这种病变后的B细胞是如何导致自体免疫反应的,这背后的机制并不清楚。另一方面,研究发现Tfh细胞能够在淋巴结生发中心(germin